The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. While it ...

Eli Lilly CEO Dave Ricks made $114 million last year, according to a new proxy statement, a rare instance of a health ...

GSK could double its long-serving CEO Emma Walmsley’s pay packet to £21.6 million ($27.2 million) after admitting its boss's current pay didn’t reward her performance and would put off future ...

Leena Nair, hailing from Kolhapur, Maharashtra, has made it to Fortune’s list as one of the ten women reshaping European industries. Her remarkable journey from a small town in India to leading one of ...

Fortune curated a list of female leaders at the helm of European companies across the continent’s biggest industries.

Onctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces the appointments of Elizabeth Holt as Chief Business Officer (CBO) and Dr Mark ...

Unilever’s revelation of the departure of Hein Schumacher – before he could celebrate a second summer as CEO – was shrouded ...

Speculation is mounting GlaxoSmithKline's CEO Emma Walmsley may pay the price for the company’s lacklustre performance, after the dreaded activist investor Elliott Management built a stake in ...

GlaxoSmithKline (GSK) has announced it is to begin searching for a successor to CEO Andrew Witty, who will retire in just over a year's time. Witty has told GSK's board that he intends to retire ...